Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 14/20 | 0.69 |
| ▸ | PPARA | Q07869 | 13/20 | 0.69 |
| ▸ | PPARD | Q03181 | 1/20 | 0.65 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.54 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1707662 | 0.90 | PPARG (0.59) | PPARGPPARAPPARDFFAR1FFAR4 | |
| SCHEMBL28216110 | 0.87 | SRR (0.61) | PPARGPPARA | |
| SCHEMBL28216109 | 0.87 | SRR (0.61) | PPARGPPARA | |
| SCHEMBL5606931 | 0.85 | PPARA (0.74) | PPARGPPARAPPARDFFAR1FFAR4 | |
| Rubidium SCHEMBL5607457 | 0.83 | PPARA (0.72) | PPARGPPARAPPARDFFAR1FFAR4 | |
| SCHEMBL5607112 | 0.83 | PPARA (0.72) | PPARGPPARAPPARDFFAR1FFAR4 | |
| SCHEMBL5606732 | 0.83 | PPARA (0.72) | PPARGPPARAPPARDFFAR1FFAR4 | |
| Ammonia Solution, Strong SCHEMBL5606255 | 0.83 | PPARA (0.72) | PPARGPPARAPPARDFFAR1FFAR4 | |
| SCHEMBL5606264 | 0.83 | PPARA (0.72) | PPARGPPARAPPARDFFAR1FFAR4 | |
| SCHEMBL5607555 | 0.83 | PPARA (0.72) | PPARGPPARAPPARDFFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070142472-A1 | Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142472-A1 | Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids | ALDH1A2, ALDH1A3, GRHPR | PPARG 1052/4885PPARA 472/4885PPARD 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.